Reduced-intensity allogeneic stem cell transplantation for co-emergence of chemotherapy-refractory follicular lymphoma and therapy-related myelodysplastic syndrome

about

Reduced-intensity allogeneic stem cell transplantation for co-emergence of chemotherapy-refractory follicular lymphoma and therapy-related myelodysplastic syndrome

Item

http://www.wikidata.org/entity/Q38737930

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Reduced-intensity allogeneic s ...... lated myelodysplastic syndrome

@en

type

Item

label

Reduced-intensity allogeneic s ...... lated myelodysplastic syndrome

@en

prefLabel

Reduced-intensity allogeneic s ...... lated myelodysplastic syndrome

@en

P1476

Reduced-intensity allogeneic s ...... lated myelodysplastic syndrome

@en

P2093

Hisao Nagoshi

http://www.w3.org/2001/XMLSchema#string

Hitoji Uchiyama

http://www.w3.org/2001/XMLSchema#string

Junya Kuroda

http://www.w3.org/2001/XMLSchema#string

Masafumi Taniwaki

http://www.w3.org/2001/XMLSchema#string

Muneo Ohshiro

http://www.w3.org/2001/XMLSchema#string

Nana Sasaki

http://www.w3.org/2001/XMLSchema#string

Shigeo Horiike

http://www.w3.org/2001/XMLSchema#string

Shinsuke Mizutani

http://www.w3.org/2001/XMLSchema#string

Tsutomu Kobayashi

http://www.w3.org/2001/XMLSchema#string

Yayoi Matsumura

http://www.w3.org/2001/XMLSchema#string

P2860

Follicular lymphoma: 2012 update on diagnosis and management

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

International scoring system for evaluating prognosis in myelodysplastic syndromes

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Bendamustine: rebirth of an old drug.

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.

P304

188-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1159/000360905

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261766398

http://www.w3.org/2001/XMLSchema#string

P698

24748869

http://www.w3.org/2001/XMLSchema#string

P932

3985782

http://www.w3.org/2001/XMLSchema#string